Our drugs engage the immune system to fight tumors
We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.
아직 댓글이 없어요. 가장 먼저 남겨보세요!
Eris Biotech에 대한 X의 실제 대화
X에 게시
